Literature DB >> 29909897

AJCC 8th Edition oral cavity squamous cell carcinoma staging - Is it an improvement on the AJCC 7th Edition?

Katherine Pollaers1, Anton Hinton-Bayre2, Peter L Friedland3, Camile S Farah4.   

Abstract

OBJECTIVES: To explore the prognostic and discriminatory ability of the AJCC 8th Edition Oral Cavity cancer staging in a non-North American population, and compare it to the previously used AJCC 7th Edition.
MATERIALS AND METHODS: Retrospective chart review was performed at a tertiary referral Otolaryngology, Head Neck and Skull Base Department in Australia, from June 2002 to June 2017. Oral cavity squamous cell carcinoma cases were staged according to AJCC 8th Edition, which was compared to AJCC 7th Edition staging, for disease-free survival (DFS) and overall survival (OS). DFS and OS were analysed using Kaplan-Meier curves.
RESULTS: There were 118 patients treated for OSCC, with an average age of 61 years, 63% were male. Overall survival grouped by stage demonstrated statistically significant discrimination between cancer stages using both the AJCC 7th and AJCC 8th Editions. AJCC 7th Edition did not discriminate between stages for DFS. Conversely, AJCC 8th Edition did statistically significantly discriminate for DFS (p = 0.0002). The DFS for both Stage 4a and 4b was significantly worse than cases in Stage 1. AJCC 8th Edition T stage was statistically significantly related to DFS (p = 0.0199), while the AJCC 7th Edition T stage was not.
CONCLUSION: The AJCC Cancer Staging Manual 8th Edition includes both the depth of primary tumour invasion and extracapsular extension of lymph node metastases. The AJCC 8th Edition OSCC staging system showed improved disease-free survival discrimination between overall stages and between T categories, while AJCC 7th Edition did not.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AJCC; Head and neck cancer; Oral cancer; Prognosis; Squamous cell carcinoma; TNM staging

Year:  2018        PMID: 29909897     DOI: 10.1016/j.oraloncology.2018.04.018

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  15 in total

1.  Regional metastasis to anatomies beyond traditional neck dissection boundaries: a multi-institutional analysis focused on unconventional metastases in oral cancer patients.

Authors:  Weijin Gao; Zhuowei Tian; Xiaodan Fang; Jincai Xue; Zhixiang Li; Cong Yang; Chunyue Ma
Journal:  World J Surg Oncol       Date:  2020-10-28       Impact factor: 2.754

2.  A Combined Prediction Model for Lymph Node Metastasis Based on a Molecular Panel and Clinicopathological Factors in Oral Squamous Cell Carcinoma.

Authors:  Shu Wang; Tiancheng Li; Huan Liu; Wei Wei; Yang Yang; Chong Wang; Bo Li; Zhengxue Han; Zhien Feng
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

3.  Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection.

Authors:  Pengfei Diao; Yaping Wu; Jin Li; Wei Zhang; Rong Huang; Chen Zhou; Yanling Wang; Jie Cheng
Journal:  J Transl Med       Date:  2018-12-18       Impact factor: 5.531

4.  lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma.

Authors:  Fubo Chen; Shengcai Qi; Xu Zhang; Jinjin Wu; Xi Yang; Raorao Wang
Journal:  Int J Oncol       Date:  2019-02-01       Impact factor: 5.650

5.  Nox4 Overexpression as a Poor Prognostic Factor in Patients with Oral Tongue Squamous Cell Carcinoma Receiving Surgical Resection.

Authors:  Yen-Hao Chen; Chih-Yen Chien; Fu-Min Fang; Tai-Lin Huang; Yan-Ye Su; Sheng-Dean Luo; Chao-Cheng Huang; Wei-Che Lin; Shau-Hsuan Li
Journal:  J Clin Med       Date:  2018-12-01       Impact factor: 4.241

6.  High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.

Authors:  Xiaoguang Li; Fengshuo Zhu; Zhonglong Liu; Xiao Tang; Yu Han; Junjian Jiang; Chunyue Ma; Yue He
Journal:  Oncol Rep       Date:  2021-01-18       Impact factor: 3.906

7.  TRIB3 promotes oral squamous cell carcinoma cell proliferation by activating the AKT signaling pathway.

Authors:  Peng Shen; Tian-Yang Zhang; Shu-Yan Wang
Journal:  Exp Ther Med       Date:  2021-02-01       Impact factor: 2.447

8.  Salvage surgery for patients with residual/persistent diseases after improper or insufficient treatment of oral squamous cell carcinoma: can we rectify these mistakes?

Authors:  Yue He; Zhonglong Liu; Surui Sheng; Weijin Gao; Xiao Tang; Xiaoguang Li; Chunyue Ma
Journal:  BMC Cancer       Date:  2021-07-31       Impact factor: 4.430

9.  Circular RNA circMDM2 accelerates the glycolysis of oral squamous cell carcinoma by targeting miR-532-3p/HK2.

Authors:  Zhao Zheng; Xiaozhou Ma; Hongfa Li
Journal:  J Cell Mol Med       Date:  2020-05-15       Impact factor: 5.310

10.  Prognostic value of systemic inflammatory markers for oral cancer patients based on the 8th edition of AJCC staging system.

Authors:  Sanghoon Lee; Dong Wook Kim; Sunmo Kwon; Hyung Jun Kim; In-Ho Cha; Woong Nam
Journal:  Sci Rep       Date:  2020-07-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.